International Biotechnology Trust PLC Omeros Corp Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $306,000 - $685,440	-34,000 Closed	0 $0
Q4 2017 Mar 02, 2018	SELL	$13.26 - $22.86 $358,020 - $617,220	-27,000 Reduced 44.26%	34,000 $660,000
Q3 2017 Mar 02, 2018	BUY	$19.76 - $24.9 $607,837 - $765,948	30,761 Added 101.73%	61,000 $1.32 Million
Q2 2017 Mar 02, 2018	BUY	N/A	30,239	30,239 $602,000

126

25.2M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $543M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.